Especially, the reduction of TS levels in SW620 cells was maintained even after sequential exposure to FTD (1.0 μM or 4.0 μM) for 24 h followed by regorafenib (10.0 μM) for 24 h. This evidence concerns the gene TYMS and frontotemporal dementia.